Merck reported EUR1.68B in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Adidas EUR 1.29B 421M Sep/2026
Adyen EUR 641.54M 60.52M Jun/2026
Akzo Nobel EUR 388M 10M Sep/2026
Alcon AG USD 728M 72M Sep/2026
Amadeus IT EUR 709.9M 37.1M Sep/2026
Amarin USD 12.54M 28.57M Jun/2025
AstraZeneca USD 7.46B 2.3B Sep/2026
BASF EUR 1.64B 806M Sep/2026
Bayer EUR 1.62B 529M Sep/2026
Beiersdorf EUR 926M 58M Jun/2026
Covestro EUR 117M 125M Dec/2025
Danone EUR 2.57B 116M Dec/2025
Fresenius EUR 912M 76M Sep/2026
Fresenius Medical Care EUR 817M 26.66M Sep/2026
Genmab DKK 401M 186M Jun/2026
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GRIFOLS EUR 505M 32M Sep/2026
Henkel EUR 1.88B 139M Dec/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Infineon EUR 1.26B 158M Jun/2026
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Linde USD 3.16B 280M Sep/2026
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.68B 82.6M Sep/2026
Novartis USD 8.62B 2.14B Sep/2026
Philips EUR 772M 138M Sep/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 5.79B 2.1B Sep/2026
UCB EUR 1.6B 570M Dec/2025